Moderna beat first-quarter expectations Thursday. The news could bolster Moderna stock which is approaching its first ...

An updated COVID booster shot can be expected this fall ... XBB.1.5 Omicron strain and is expected to be effective against ...

All vaccines have at least occasional side effects. But people who say they were injured by COVID vaccines believe their cases have been ignored.

The Centers for Disease Control and Prevention endorsed Moderna and Pfizer’s coronavirus booster shots for all adults Friday ... “I think that there will be requirements from the FDA with full ...

director of the FDA's Center for Biologics Evaluation and Research, told reporters. As of Sunday, 73% of adults in the U.S. have had at least one dose of the Pfizer, Moderna or Johnson & Johnson ...

Sharp-eyed grocery shoppers may notice new labels in the dairy aisle touting yogurt as way to reduce the risk of Type 2 ...

The FDA approved the subcutaneous form as a maintenance ... UC treatment or other treatments did not work well enough. Pfizer-BioNTech’s and Moderna’s mRNA-based COVID-19 vaccines have been ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed by Pfizer and BioNTech ... and greater efficacy than shots made using traditional ...

Hong Kong will make BioNTech coronavirus booster shots available to all age-eligible city residents from January, the city’s leader has announced. But Chief Executive Carrie Lam Cheng Yuet-ngor ...

The XBB.1.5 subvariant — nicknamed ‘Kraken’ — is arguably the most genetically rich and most transmissible SARS-CoV-2 omicron subvariant yet. News Wrap: Russia shells Bakhmut in eastern ...